RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. OrbiMed
O

OrbiMed portfolio

OrbiMed has 22 portfolio companies on record at Recent Funding, with 8 investments in the last 12 months.

Website: orbimed.com.
Type: Crossover fund.
Portfolio on Recent Funding: 22.
Deals, last 12 months: 8.
Rounds led: 10 of 32.
Capital in their rounds: $3.85B.
Latest deal: Dren Bio · Oct 29, 2026.
About this page

It is a crossover fund based in New York, US, founded in 1989. It led 10 of the 32 rounds it joined. Its most recent investment on record is Dren Bio's $350M funding round in October 2026, alongside Taiho Ventures, General Catalyst, HBM Healthcare Investments and 6 others. By category, its portfolio leans toward Health and bio (22) and Consumer and social (2). It has co-invested with SR One, RA Capital Management and Cormorant Asset Management, most often SR One (6 rounds).

About OrbiMed

Firm type: Crossover fund.
Headquarters: New York, US.
Founded: 1989.
Stages: Seed, Series A, Series B, Series C, Growth, Late Stage.
Sectors: AI & Machine Learning, Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
Check size: $1M to $75M.
Leads rounds: Yes.
Portfolio companies: 222.
Exits: 4.
Rounds led: 16.

Fund returns

FundVintageSizeNet IRRTVPIDPIAs of
OrbiMed Private Investments IX, LP2022—29.3%1.16x0.21xSep 30, 2025
OrbiMed Royalty & Credit Opportunities IV2022—14.1%1.28x0.25xSep 30, 2025
OrbiMed Royalty & Credit Opportunities III, LP2019—15.1%1.20x0.95xJun 30, 2025
Orbimed Private lnvesuncnts IV, L P2009—36.2%2.67x0.45xJun 30, 2016
Orbimed Private Investments III, LP2006—18.1%2.34x1.48xDec 31, 2016
Orbimed Private lnvesunents Ill, LP2006—18.4%2.32x—Jun 30, 2016

What OrbiMed invests in

OrbiMed recent investments

How OrbiMed invests

StageDealsCapital in rounds
Series B+ 20 63%$1.55B
Series A 10 31%$1.94B
Seed 1 3%$6.5M
round 1 3%$350M
YearDealsCapital in rounds
2018 1 3%$10M
2019 2 6%$32.5M
2020 1 3%$70M
2021 1 3%$80M
2022 3 9%$471.5M
2023 5 16%$335M
2024 4 13%$450M
2025 8 25%$1.28B
2026 7 22%$1.12B

OrbiMed portfolio companies

CompanyRound with OrbiMedTotal raisedLatest raise
DDren Bio
Health and bio
round · $350M$415MOct 29, 2026
round
SStar Therapeutics
Health and bio
Series B+ · $200M · lead$415MOct 23, 2026
Series B+
FFore Biotherapeutics
Health and bio
Series B+ · $67.4M$182.4MJul 8, 2026
Series B+
PPinnacle Medicines
Health and bio
Series B+ · $89M$89MMar 26, 2026
Series B+
AAngitia Bio
Health and bio
Series B+ · $130M$130MFeb 12, 2026
Series B+
MMendra
Health and bio
Series A · $82M · lead$82MJan 29, 2026
Series A
AAirNexis Therapeutics
Health and bio
Series A · $200M$200MJan 9, 2026
Series A
AAspen Neuroscience
Health and bio
Series B+ · $115M · lead$339MNov 20, 2025
Series B+
TTreeline Biosciences
Health and bio
Series A · $200M$461MSep 3, 2025
Series A
PProVerum
Health and bio
Series B+ · $80M$118.16MAug 25, 2025
Series B+
RRayThera
Health and bio
Series A · $110M · lead$110MApr 4, 2025
Series A
WWindward Bio
Health and bio
Series A · $200M · lead$200MMay 5, 2026
round
VVerdiva Bio
Health and bio
Series A · $410M$410MJan 9, 2025
Series A
KKapiva
Health and bio
Series B+ · $10M · lead$70MSep 29, 2025
Series B+
MMirador Therapeutics
Health and bio
Series A · $400M · lead$650MJan 13, 2026
Series B+
NNoctrix Health
Health and bio
Series B+ · $40M$73.5MSep 2, 2025
round
KKoya Medical
Health and bio
Series B+ · $30M · lead$56MNov 15, 2023
Series B+
AAmolyt Pharma
Health and bio
Series B+ · $140M$294MJan 6, 2023
Series B+
MMdclone
Health and bio
Series B+ · $63M$99MMar 1, 2022
Series B+
LLaekna Therapeutics
Health and bio
backer$61MMay 18, 2022
Series B+
CCurevo Vaccine
Health and bio
backerundisclosedMar 18, 2025
Series B+
HHelicore
Health and bio
backerundisclosedJan 28, 2025
Series A

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Net returns as reported by the public-pension and foundation LPs invested in each fund.

Firm profile and fund returns: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 32 rounds on Recent Funding that name OrbiMed. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists OrbiMed, which is a subset of its real portfolio. API: /api/v1/investors/orbimed (get a free API key). More: the most active VC firms and new venture capital funds.

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy